MRI and Clinical Features of Nonenhancing <i>IDH</i> -Wild-Type Glioblastomas: How to Make an Early Diagnosis and Distinguish from Mimics
BACKGROUND AND PURPOSE: -wt GBMs to help radiologists in differentiating them from nonmalignant mimic diagnoses (eg, encephalitis). Additionally, the histologic, genomic, and survival profiles of nonenhancing GBMs were compared with those of enhancing GBMs. MATERIALS AND METHODS: -wt GBMs with nonmalignant mimics. Histopathologic and genomic analyses were performed on institutional cases. Overall survival between nonenhancing and enhancing GBMs was compared using Kaplan-Meier analysis. RESULTS: = .078). CONCLUSIONS: Nonenhancing GBMs demonstrate distinct MRI features that must be recognized for early diagnosis and differentiation from nonmalignant mimics. Nonenhancing GBMs demonstrated longer overall survival compared with enhancing GBMs, though they were not statistically significant.
Authors
- James Ryan Loftus (ORCID: https://orcid.org/0000-0001-7059-1158)
- Sonal Patel
- Daniel Orringer
- Rajan Jain
- Matija Snuderl
- Kanwar P. Singh (ORCID: https://orcid.org/0000-0002-4669-906X)
- Matthew D. Lee (ORCID: https://orcid.org/0000-0001-8816-1076)
Institutions
- University of Virginia Medical Center (US)
- New York University (US)
Publication Details
- Journal
- American Journal of Neuroradiology
- Published
- 2026-05-01
- DOI
- https://doi.org/10.3174/ajnr.a9272
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00